Since mutant NRAS is known to drive glutamine dependency in melanoma17, we investigated the effect of glutamine supplementation in HMCB xenografts, which express wild-type BRAF and mutant NRAS, and found that increased glutamine intake hindered growth in these tumours compared to the control diet group (Supplementary Fig. 1a, b). Here, BRAF is linked to neoplasm.